Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial

There is no fulltext present in this item.

Title:	Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial
Author(s):	Topol, E.; Califf, R.M.; Simes, R.J.; Werf, F. van de; Diaz, R.; Paoloasso, E.; Aylward, P.; Keech, A.; Klein, W. ; Piegas, L.; Tomov, I.; Armstrong, P.W.; Widimsky, P.; Grande, P.; Halinen, M.; Vahanian, A.; Neuhaus, K.; Dimas, A.P.; White, H.; Preda, I.; Kristinsson, A.; Ardissino, D.; Tzivoni, D.; Madsen, S.; Sugrue, D.; Sadowski, Z.; Seabra-Gomes, R.; Apetrei, E.; Dalby, A.; Betriu, A.; Pfisterer, M.; Verheugt, F.W.A. ; Fox, K.; Bates, E.R.; Gibler, W.B.; Granger, C.; Harrington, R.A.; Hochman, J.S.; Holmes, D.R.; Kleiman, N.S.; Lee, K.L.; Molietrno, D.J.; Newby, L.K.; Ohman, E.M.
Publication year:	2000
Source:	The Lancet (London), vol. 355, (2000), pp. 337-345
Number of Pages:	15 p.
ISSN:	0140-6736
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/185898
Display more details
Subject:	Reperfusion therapy in acute coronary syndromes Reperfusietherapie bij acute coronaire syndromen
Organization:	Taalwetenschap Cardiology
Journal title:	The Lancet (London)
Volume:	vol. 355
Page start:	p. 337
Page end:	p. 345